Biomedical Engineering Reference
In-Depth Information
References
Apostolou, E. and Hochedlinger, K. (2011) 'Stem cells: iPS cells under attack',
Nature
,
474 (9 June): 165-6.
Baker, M. (2009) 'Stem cells: fast and furious',
Nature
,
458 (22 April):
962-5.
Ben-Nun, I., Montague, S., Houck, M., Tran, H., Garitaonandia, I. et al.
(2011) 'Induced pluripotent stem cells from highly endangered species',
Nature Methods
,
4 September (online).
Callaway, E. (2011a) 'Cells snag top modelling job',
Nature
, 469 (17
January): 279.
Callaway, E. (2011b) 'Schizophrenia “in a dish”',
Nature
,
13 April (online).
Cardona, B. (2009) '“Anti-ageing medicine” in Australia: global trends and
local practices to redefine ageing',
Health Sociology Review
,
18 (4):
446-60.
Carpenter, K., Frey-Vasconcells, J. and Rao, M. (2009) 'Developing safe
therapies from human pluripotent stem cells',
Nature Biotechnology
,
27
(7): 606-13.
Colman, A. and Dressen, O. (2009) 'Pluripotent stem cells and disease
modeling',
Cell Stem Cell
,
5 (3): 244-7.
Courtney, A., de Sousa, P., George, C., Laurie, G. and Tait, J. (2011)
'Balancing open source stem cell science with commercialization',
Nature Biotechnology
,
29 (7 February): 115-16.
Crook, J., Hei, D. and Stacey, G. (2010) 'The International Stem Cell
Banking Initiative (ISCBI): raising standards to bank on',
In Vitro
Cellular and Developmental Biology - Animal
,
46 (3-4): 169-72.
Cyranowksi, D. (2010) 'Disease-in-a-dish approach gives clues to Rett
syndrome',
Nature
,
17 November (online).
Daniels, J., Secker, G., Shortt, A., Tuft, S. and Seetharaman, S. (2006) 'Stem
cell delivery: treading the regulatory tightrope',
Regenerative Medicine
,
1 (5): 715-19.
Deeds, D. and Hill, C. (1996) 'Strategic alliances and the rate of new
product development: an empirical study of entrepreneurial biotechnology
firms',
Journal of Business Venturing
,
11 (1): 41-55.
Eisenstein, M. (2010) 'Up for grabs',
Nature Biotechnology
,
38 (6): 544-6.
Fisken, J. and Rutherford, J. (2002) 'Business models and investment trends
in the biotechnology industry in Europe',
Journal of Commercial
Biotechnology
, 8 (3): 191-9.
Giordano, R., Lazzari, L. and Rebulla, P. (2004) 'Clinical grade cell
manipulation',
Vox Sanguinis
, 87 (2): 65-72.
